International Biotechnology Trust as of Sept. 30, 2021
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 68 positions in its portfolio as reported in the September 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Gilead Sciences (GILD) | 6.9 | $28M | 403k | 69.82 | |
Neurocrine Biosciences (NBIX) | 6.8 | $28M | 290k | 95.82 | |
Horizon Therapeutics Pub SHS | 6.4 | $26M | 238k | 109.48 | |
Amgen (AMGN) | 6.1 | $25M | 118k | 212.56 | |
Biohaven Pharmaceutical Holding | 6.0 | $25M | 176k | 138.83 | |
Seagen | 4.6 | $19M | 110k | 169.72 | |
Incyte Corporation (INCY) | 4.5 | $19M | 270k | 68.76 | |
Mirati Therapeutics | 4.3 | $17M | 99k | 176.84 | |
Ptc Therapeutics I (PTCT) | 4.1 | $17M | 449k | 37.22 | |
Alnylam Pharmaceuticals (ALNY) | 3.5 | $14M | 75k | 188.80 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.4 | $14M | 77k | 181.39 | |
Illumina (ILMN) | 2.7 | $11M | 27k | 405.33 | |
Exelixis (EXEL) | 2.5 | $10M | 490k | 21.13 | |
Ultragenyx Pharmaceutical (RARE) | 2.3 | $9.3M | 103k | 90.07 | |
Turning Point Therapeutics I | 2.3 | $9.2M | 139k | 66.43 | |
Travere Therapeutics (TVTX) | 2.3 | $9.2M | 380k | 24.25 | |
Harmony Biosciences Hldgs In (HRMY) | 2.2 | $9.0M | 236k | 38.22 | |
Supernus Pharmaceuticals (SUPN) | 1.9 | $7.9M | 298k | 26.67 | |
Biogen Idec (BIIB) | 1.8 | $7.2M | 26k | 282.82 | |
Kalvista Pharmaceuticals (KALV) | 1.6 | $6.7M | 383k | 17.45 | |
Insmed (INSM) | 1.6 | $6.6M | 241k | 27.53 | |
Uniqure Nv SHS (QURE) | 1.4 | $5.8M | 182k | 32.02 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.4 | $5.8M | 44k | 130.20 | |
Ascendis Pharma AS Sponsored ADR (ASND) | 1.1 | $4.7M | 29k | 159.39 | |
Regeneron Pharmaceuticals (REGN) | 1.1 | $4.7M | 7.7k | 604.68 | |
Guardant Health (GH) | 1.1 | $4.6M | 37k | 125.01 | |
BioMarin Pharmaceutical (BMRN) | 1.0 | $4.3M | 55k | 77.29 | |
Zai Lab Adr (ZLAB) | 1.0 | $4.1M | 39k | 105.19 | |
Dyne Therapeutics (DYN) | 1.0 | $4.1M | 250k | 16.24 | |
Chinook Therapeutics | 0.7 | $3.0M | 235k | 12.73 | |
Intra Cellular Therapies (ITCI) | 0.7 | $3.0M | 80k | 37.22 | |
Ideaya Biosciences (IDYA) | 0.7 | $2.8M | 109k | 25.49 | |
Aurinia Pharmaceuticals (AUPH) | 0.7 | $2.7M | 124k | 22.06 | |
Sutro Biopharma (STRO) | 0.6 | $2.6M | 139k | 18.87 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 0.6 | $2.5M | 50k | 50.44 | |
Hutchmed China Sponsored Ads (HCM) | 0.6 | $2.5M | 68k | 36.53 | |
Enanta Pharmaceuticals (ENTA) | 0.6 | $2.3M | 40k | 56.58 | |
Zogenix Com New | 0.5 | $2.1M | 135k | 15.19 | |
Blueprint Medicines (BPMC) | 0.5 | $2.0M | 20k | 102.72 | |
Rocket Pharmaceuticals (RCKT) | 0.5 | $1.9M | 63k | 29.89 | |
Harpoon Therapeutics | 0.4 | $1.7M | 215k | 7.89 | |
Allakos (ALLK) | 0.4 | $1.7M | 16k | 105.86 | |
Fate Therapeutics (FATE) | 0.4 | $1.7M | 28k | 59.29 | |
Chemocentryx | 0.4 | $1.6M | 94k | 17.09 | |
Springworks Therapeutics (SWTX) | 0.4 | $1.6M | 25k | 63.28 | |
Nkarta (NKTX) | 0.4 | $1.6M | 56k | 27.81 | |
Kodiak Sciences (KOD) | 0.4 | $1.6M | 16k | 95.86 | |
Ionis Pharmaceuticals (IONS) | 0.4 | $1.5M | 45k | 33.54 | |
Iovance Biotherapeutics (IOVA) | 0.3 | $1.4M | 58k | 24.66 | |
I Mab Sponsored Ads (IMAB) | 0.3 | $1.3M | 18k | 72.28 | |
Arena Pharmaceuticals | 0.3 | $1.2M | 21k | 59.52 | |
Nektar Therapeutics (NKTR) | 0.3 | $1.2M | 67k | 17.93 | |
Oric Pharmaceuticals (ORIC) | 0.3 | $1.1M | 53k | 20.83 | |
EXACT Sciences Corporation (EXAS) | 0.2 | $1.0M | 11k | 95.42 | |
Agios Pharmaceuticals (AGIO) | 0.2 | $992k | 22k | 46.14 | |
Amicus Therapeutics (FOLD) | 0.2 | $904k | 95k | 9.56 | |
Deciphera Pharmaceuticals | 0.1 | $564k | 17k | 33.98 | |
Global Blood Therapeutics In | 0.1 | $555k | 22k | 25.46 | |
Immunovant (IMVT) | 0.1 | $521k | 60k | 8.68 | |
Axsome Therapeutics (AXSM) | 0.1 | $461k | 14k | 32.93 | |
Gamida Cell SHS | 0.1 | $418k | 107k | 3.91 | |
Xenon Pharmaceuticals (XENE) | 0.1 | $388k | 26k | 15.22 | |
Black Diamond Therapeutics (BDTX) | 0.1 | $371k | 44k | 8.43 | |
Anaptysbio Inc Common (ANAB) | 0.1 | $271k | 10k | 27.10 | |
Relmada Therapeutics (RLMD) | 0.1 | $261k | 10k | 26.10 | |
Bluebird Bio (BLUE) | 0.1 | $210k | 11k | 19.09 | |
Fibrogen (FGEN) | 0.0 | $201k | 20k | 10.20 | |
Esperion Therapeutics (ESPR) | 0.0 | $114k | 9.5k | 12.00 |